Videos

Intervening Early in MS With Exercise: Ulrik Dalgas, PhD

Charlene Gamadelo, MD, provides an overview of insomnia and discusses the prevalence by race and gender, the variations in presentation of symptoms in patients, and the pathways involved in sleep wakefulness cycles.

Ulrik Dalgas, PhD

The Impact of COVID-19 and Vaccinations for MS Patients: Tianrong Yeo, PhD, MBBS, MRCP, MMED, FAMS, MCI

The professor of public health and sports science at Aarhus University shared his perspective on the potential to modify multiple sclerosis disease progression with lifestyle interventions. [WATCH TIME: 2 minutes]

Tianrong Yeo, PhD, MBBS, MRCP, MMED, FAMS, MCI

MS Field Focused on Slowing Disease Progression: Tianrong Yeo, PhD, MBBS, MRCP, MMED, FAMS, MCI

The senior consultant for the department of neurology at the National Neuroscience Institute shared more details about his presentation that he gave at the 38th ECTRIMS Congress. [WATCH TIME: 6 minutes]

Tianrong Yeo, PhD, MBBS, MRCP, MMED, FAMS, MCI

Resources for Sleep Disorders

The senior consultant for the department of neurology at the National Neuroscience Institute discussed his thoughts on improvements in the MS field in relation to this year's ECTRIMS conference. [WATCH TIME: 4 minutes]

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Unmet Needs in Sleep Disorder Management

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Emerging Treatment Options for Sleep Disorders

Nathaniel F. Watson, MD, leads a discussion on gaps in care and unmet needs for patients and healthcare professionals in the area of sleep disorders.

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Newest Updates in Multiple Sclerosis at ECTRIMS 2022: Tianrong Yeo, MBBS, MRCP, MMED, FAMS, MCI, PhD

Experts in sleep medicine share emerging treatments in the pipeline for the management of sleep disorders.

Tianrong Yeo, PhD, MBBS, MRCP, MMED, FAMS, MCI

IFN 2022 Expands on Neurology Specialties and Positive Brain Health: Stephen Krieger, MD

The senior consultant for the department of neurology at the National Neuroscience Institute shares what he looks forward to at this year's ECTRIMS conference. [WATCH TIME: 2 minutes]

Stephen Krieger, MD

October 25th 2022

Assessing Treatment Decisions for Myasthenia Gravis: George Small, MD

The neurologist at the Corinne Goldsmith Dickinson Center for MS offered a brief overview of his experience at the 2022 IFN conference held in New York City on September 23-24. [WATCH TIME: 4 minutes]

George Small, MD

October 25th 2022

Treatment Adherence in Sleep Disorders

The adult neurologist at Allegheny Health Network provided insight on the steps taken to ensure a patient with myasthenia gravis is on an effective and safe therapy. [WATCH TIME: 7 minutes]

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Selecting Specific DORAs for Insomnia

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson examine setting treatment expectations with patients and treatment adherence for sleep disorders.

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Medical Crossfire on the Paradigm Shifts in Migraine Therapy: Jessica Ailani, MD

Ashgan A. Elshinawy, DO, shares her approach to treatment selection of DORAs and switching therapies for the management of sleep disorders.

Jessica Ailani, MD

Current State of Treating, Managing Myasthenia Gravis: George Small, MD

The director of the MedStar Georgetown University Hospital Headache Center tells her experience in a medical crossfire as the migraine cochair at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 5 minutes]

George Small, MD

The Benefits of Cross-Specialty Interaction at IFN 2022: Jessica Ailani, MD

The adult neurologist at Allegheny Health Network provided insight on the current state of care for myasthenia gravis and strides the community has made in recent decades. [WATCH TIME: 7 minutes]

Jessica Ailani, MD

October 23rd 2022

Positive Interim Report on Fosgonimeton, Lower ASPECTS Scores Impact Efficacy of EVT, FDA Extends Review of Tofersen

The director of the MedStar Georgetown University Hospital Headache Center shares her experience as the migraine cochair at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 5 minutes]

NeurologyLive® Staff

October 22nd 2022

Phase 3 Studies With Daridorexant for Insomnia Management

Neurology News Network for the week ending October 22, 2022. [WATCH TIME: 4 minutes]

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

FDA-Approved Therapies for the Management of Sleep Disorders

Nathaniel F. Watson, MD, highlights the use of daridorexant for treating patients with insomnia as seen from phase 3 trials and data presented at the World Sleep 2022 meeting and managing adverse events.

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Impact of NMOSD on Women’s Health

Drs Ashgan A. Elshinawy, C. Michael Gibson, and Nathaniel F. Watson discuss FDA-approved medications currently used for the treatment of sleep disorders and insomnia, and comment on the difference between DORAs.

Michael Yeaman, PhD;Mirla Avila, MD;Michael Levy, MD, PhD;Mitzi Williams, MD

Current FDA-Approved Therapies for NMOSD Management

Experts in neurology review the occurrence and severity of infections in women and special patient populations with NMOSD and share their thoughts on the use of vaccines to prevent infections.

Michael Yeaman, PhD;Mirla Avila, MD;Michael Levy, MD, PhD;Mitzi Williams, MD

Monoclonal Antibodies for Alzheimer Disease and Lecanemab’s Potential: Richard Isaacson, MD

Michael Levy, MD, PhD, leads a discussion on the safety and efficacy of FDA-approved therapies for the management of NMOSD.

Richard S. Trosh, MD

Differences Between Fenebrutinib and Other BTK Inhibitors: Stuart Silverman, MD

The director of the Center for Brain Health and Alzheimer prevention clinic at FAU medicine shares his experience during the Medical Crossfire session on the Alheimer pipeline that he took part in at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 7 minutes]

Stuart Silverman, MD

Focusing on the Future of Neurology at IFN 2022: Richard Isaacson, MD

The neurologist at Allegheny Health Network’s Neuroscience Institute provided insight on the mechanism of action of fenebrutinib and how it differs from other BTK inhibitors currently in development. [WATCH TIME: 3 minutes]

Richard Isaacson, MD

October 20th 2022

Sleep Disorders: Sleep and Wakefulness Pathways

The director of the Center for Brain Health and Alzheimer prevention clinic at FAU medicine provides commentary about his time at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 4 minutes]

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Treatment Selection for Sleep Disorders

Nathaniel F. Watson, MD, reviews the pathways involved in sleep and wakefulness cycles as it relates to sleep disorders.

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

Exponential Growth of Research, Biomarkers in Alzheimer Disease: Thomas Wisniewski, MD

Dr Ashgan A. Elshinawy and C. Michael Gibson considers safety and efficacy factors when approaching treatment selection for sleep disorders and insomnia.

Thomas Wisniewski, MD

IFN 2022 Recap With the Dementia Chair: Richard Isaacson, MD

The director of NYU Langone’s Alzheimer’s Disease Research Center discussed noticeable advancements within the field of Alzheimer disease in recent years and how they contribute to gaining a better understanding of the disease. [WATCH TIME: 5 minutes]

Richard S. Trosh, MD

Understanding the Utility of Specific Antibody Testing in Peripheral Neuropathies: Benjamin Claytor, MD

The director of the Center for Brain Health and Alzheimer prevention clinic at FAU medicine shares his experience at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 3 minutes]

Benjamin Claytor, MD

October 18th 2022

Role of Patient Communication in Sleep Disorder Management

The assistant professor of neurology at Cleveland Clinic provided insight on the differences in ganglioside vs paranodal antibodies and their clinical use in various neuropathies. [WATCH TIME: 3 minutes]

C. Michael Gibson, MD;Nathaniel F. Watson, MD;Ashgan Elshinawy, DO

October 17th 2022